You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist
Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease
Part of the
Corewell Health Metabolomics Symposium
Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease
Related articles
- UDCA – reducing inflammation and supporting bile flow
- Population based medicine – Transform medicine with metabolomics – part 4 of 5
- Spermidine – Unlocking the secrets of cellular aging and longevity
- Precision medicine – Transform medicine with metabolomics – part 3 of 5
- Propionic acid – A short-chain fatty acid with big impact
